Medicus Pharma Ltd. Common Stock (MDCX) Financials
MDCX Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 27.1 million | 28.8 million |
| March 31, 2026 | 7.4 million | 6.0 million |
| Dec. 31, 2025 | 7.3 million | 7.3 million |
| Sept. 30, 2025 | 10.0 million | 10.8 million |
MDCX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | -9.4 million | 2.0 million |
| March 31, 2026 | -6.5 million | 599306 |
| Dec. 31, 2025 | -4.6 million | 429712 |
| Sept. 30, 2025 | -6.8 million | 852757 |
MDCX Net Income
No data available :(
MDCX Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 15.2 million | - | - |
| March 31, 2026 | 6.4 million | 24168 | 169624 |
| Dec. 31, 2025 | 6.4 million | 18869 | 43873 |
| Sept. 30, 2025 | 8.7 million | 95188 | 236258 |
MDCX Shares Outstanding
MDCX Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | 5 | 4.9 million | 6.6 million | - |
| March 31, 2026 | - | 2.7 million | 5.9 million | - |
| Dec. 31, 2025 | 3 | 2.6 million | 5.2 million | - |
| Sept. 30, 2025 | - | 10.4 million | 5.0 million | - |
MDCX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | - | - |
| March 31, 2026 | - | - |
| Dec. 31, 2025 | - | - |
| Sept. 30, 2025 | - | - |
MDCX
Price: $2.66
52 week price:
Earnings Per Share: -2.63 USD
Exchange: NCM
Sector: Healthcare
Industry: Drug Manufacturers - General
Market Capitalization: 10.6 million